| Lori Pavlack, | |
|
1897 Sundance Rdg, Howell, MI 48843-6986 | |
| (517) 552-5638 | |
| Not Available |
| Full Name | Lori Pavlack |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1897 Sundance Rdg, Howell, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457677809 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lori Pavlack, 1897 Sundance Rdg, Howell, MI 48843-6986 Ph: () - | Lori Pavlack, 1897 Sundance Rdg, Howell, MI 48843-6986 Ph: (517) 552-5638 |
News Archive
A new study by researchers at NYU Langone Medical Center found a high desire for additional genetic testing among consumers for life altering and threatening medical conditions including mental retardation, blindness, deafness, cancer, heart disease, dwarfism and shortened lifespan from death by 5 years of age.
A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to research published in the August issue of the Journal of Thoracic Oncology, the official monthly journal of the International Association for the Study of Lung Cancer.
Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation of trazodone.
A large observational study was presented at the Acute Cardiovascular Care 2019 a European Society of Cardiology (ESC) congress. It has found that heart attack patients survive longer if they are taken to heart centres early.
› Verified 8 days ago
Meagan Atkins, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 138 W Highland Rd, Howell, MI 48843 Phone: 517-376-4831 Fax: 517-376-4833 | |
Mrs. Emily Lynn-otto Christensen, M.A., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 138 W Highland Rd Ste 500-600, Howell, MI 48843 Phone: 517-376-4831 Fax: 517-376-4833 | |
Karrie Deland, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5010 Caramae Ln, Howell, MI 48855 Phone: 810-938-0378 | |
Ms. Elizabeth Kathleen Hartmann, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1425 W Grand River Ave, Howell, MI 48843 Phone: 517-546-5550 | |
Bailey Chavez, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 138 W Highland Rd Ste 500, Howell, MI 48843 Phone: 517-376-4831 | |
Bailee Lawrence, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 138 W Highland Rd Ste 500-600, Howell, MI 48843 Phone: 517-376-4831 | |
Mrs. Jenna Lynn Marr, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 138 W. Highland Rd., Suite 500-600, Howell, MI 48843 Phone: 517-376-4831 Fax: 517-376-4833 |